04/26/2024
Read about Sarah's experience and the impact genetic testing has had on her family, especially when coupled with the accessibility and ease-of-use offered by a saliva-based at-home, collection kit. https://bit.ly/444w2AM
Introducing Clarifi™: the non-invasive saliva test that aids in the early diagnosis of autism spectrum disorder in children under six.
505 Irving Avenue Suite 3100AB
Syracuse, NY
13210
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |
| Saturday | 8am - 4pm |
| Sunday | 8am - 4pm |
Be the first to know and let us send you an email when Quadrant Laboratories posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Clarifi ASD is designed to provide a probability of an autism diagnosis based on epigenetic biomarkers in the saliva.
This saliva-based test provides objective support for earlier diagnosis, when treatment is most efficacious. It can be administered on children 18 months through 6 years old (i.e., until the child’s 7th birthday) with a clinician suspicion of ASD. Clarifi ASD is a diagnostic aid and should be used in combination with developmental and behavioral assessments, like the MCHAT. A high probability Clarifi test may give parents and clinicians more confidence to diagnosis a child with autism and start early intervention services, rather than putting them on a waiting list. It can also be used to help determine the urgency of a specialist referral. Learn more about the test at ClarifiASD.com.